These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 11991532)

  • 1. Determination of MDMA and its metabolites in blood and urine by gas chromatography-mass spectrometry and analysis of enantiomers by capillary electrophoresis.
    Pizarro N; Ortuño J; Farré M; Hernández-López C; Pujadas M; Llebaria A; Joglar J; Roset PN; Mas M; Segura J; Camí J; de la Torre R
    J Anal Toxicol; 2002 Apr; 26(3):157-65. PubMed ID: 11991532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolites in plasma and urine by HPLC-DAD and GC-MS.
    Helmlin HJ; Bracher K; Bourquin D; Vonlanthen D; Brenneisen R
    J Anal Toxicol; 1996 Oct; 20(6):432-40. PubMed ID: 8889680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitive gas chromatography-mass spectrometry method for simultaneous measurement of MDEA, MDMA, and metabolites HMA, MDA, and HMMA in human urine.
    Pirnay SO; Abraham TT; Huestis MA
    Clin Chem; 2006 Sep; 52(9):1728-34. PubMed ID: 16858076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-dimensional gas chromatography/electron-impact mass spectrometry with cryofocusing for simultaneous quantification of MDMA, MDA, HMMA, HMA, and MDEA in human plasma.
    Kolbrich EA; Lowe RH; Huestis MA
    Clin Chem; 2008 Feb; 54(2):379-87. PubMed ID: 18089653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gas chromatography-ion trap mass spectrometry method for the simultaneous measurement of MDMA (ecstasy) and its metabolites, MDA, HMA, and HMMA in plasma and urine.
    da Silva DG; de Pinho PG; Pontes H; Ferreira L; Branco P; Remião F; Carvalho F; Bastos ML; Carmo H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Mar; 878(9-10):815-22. PubMed ID: 20167546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereochemical analysis of 3,4-methylenedioxymethamphetamine and its main metabolites by gas chromatography/mass spectrometry.
    Pizarro N; Llebaria A; Cano S; Joglar J; Farré M; Segura J; de la Torre R
    Rapid Commun Mass Spectrom; 2003; 17(4):330-6. PubMed ID: 12569443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of MDMA and its metabolites in urine and plasma following a neurotoxic dose of MDMA.
    Valtier S; Phelix CF; Cody JT
    J Anal Toxicol; 2007 Apr; 31(3):138-43. PubMed ID: 17579960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary MDMA, MDA, HMMA, and HMA excretion following controlled MDMA administration to humans.
    Abraham TT; Barnes AJ; Lowe RH; Kolbrich Spargo EA; Milman G; Pirnay SO; Gorelick DA; Goodwin RS; Huestis MA
    J Anal Toxicol; 2009 Oct; 33(8):439-46. PubMed ID: 19874650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct determination of glucuronide and sulfate of 4-hydroxy-3-methoxymethamphetamine, the main metabolite of MDMA, in human urine.
    Shima N; Kamata H; Katagi M; Tsuchihashi H; Sakuma T; Nemoto N
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Sep; 857(1):123-9. PubMed ID: 17643356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of LC-HRMS and GC-NICI-MS methods for stereoselective determination of MDMA and its phase I and II metabolites in human urine.
    Schwaninger AE; Meyer MR; Huestis MA; Maurer HH
    J Mass Spectrom; 2011 Jul; 46(7):603-14. PubMed ID: 21656610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enantioselective determination of 3,4-methylene-dioxymethamphetamine and two of its metabolites in human urine by cyclodextrin-modified capillary zone electrophoresis.
    Lanz M; Brenneisen R; Thormann W
    Electrophoresis; 1997 Jun; 18(6):1035-43. PubMed ID: 9221895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-linear pharmacokinetics of MDMA ('ecstasy') in humans.
    de la Torre R; Farré M; Ortuño J; Mas M; Brenneisen R; Roset PN; Segura J; Camí J
    Br J Clin Pharmacol; 2000 Feb; 49(2):104-9. PubMed ID: 10671903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous determination of amphetamine, methamphetamine, methylenedioxyamphetamine (MDA), methylenedioxymethamphetamine (MDMA), and methylenedioxyethylamphetamine (MDEA) enantiomers by GC-MS.
    Hensley D; Cody JT
    J Anal Toxicol; 1999 Oct; 23(6):518-23. PubMed ID: 10517560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validated liquid chromatographic-electrospray ionization mass spectrometric assay for simultaneous determination of 3,4-methylenedioxymethamphetamine and its metabolites 3,4-methylenedioxyamphetamine, 3,4-dihydroxymethamphetamine, and 4-hydroxy-3-methoxymethamphetamine in squirrel monkey plasma.
    Mueller M; Peters FT; Ricaurte GA; Maurer HH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Aug; 855(2):262-70. PubMed ID: 17646137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of MDMA and its metabolites in urine by GC and GC/MS].
    Shen M; Yan W; Shen B; Xiang P; Huang Z; Liu W; Bo J
    Fa Yi Xue Za Zhi; 1998; 14(1):10-1, 24, 61. PubMed ID: 11360579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hair analysis for drug abuse. XV. Disposition of 3, 4-methylenedioxymethamphetamine (MDMA) and its related compounds into rat hair and application to hair analysis for MDMA abuse.
    Kikura R; Nakahara Y; Mieczkowski T; Tagliaro F
    Forensic Sci Int; 1997 Jan; 84(1-3):165-77. PubMed ID: 9042722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine after controlled oral administration to young adults.
    Kolbrich EA; Goodwin RS; Gorelick DA; Hayes RJ; Stein EA; Huestis MA
    Ther Drug Monit; 2008 Jun; 30(3):320-32. PubMed ID: 18520604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of an LC-MS/MS method after chiral derivatization for the simultaneous stereoselective determination of methylenedioxy-methamphetamine (MDMA) and its phase I and II metabolites in human blood plasma.
    Steuer AE; Schmidhauser C; Liechti ME; Kraemer T
    Drug Test Anal; 2015 Jul; 7(7):592-602. PubMed ID: 25371386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of 3,4-methylenedioxymetamphetamine and its metabolites in plasma and urine by gas chromatography with nitrogen-phosphorus detection.
    Ortuño J; Pizarro N; Farré M; Mas M; Segura J; Camí J; Brenneisen R; de la Torre R
    J Chromatogr B Biomed Sci Appl; 1999 Feb; 723(1-2):221-32. PubMed ID: 10080649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of enantioselective high-performance liquid chromatography-tandem mass spectrometry method for the quantitative determination of 3,4-methylenedioxy-methamphetamine (MDMA) and its phase-1 metabolites in human biological fluids.
    Lo Faro AF; Sprega G; Beradinelli D; Tini A; Poyatos L; Papaseit E; Berretta P; Di Giorgi A; Farre M; Takaishvili N; Farkas T; Busardò FP; Chankvetadze B
    J Pharm Biomed Anal; 2024 Jan; 238():115768. PubMed ID: 37979525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.